Association between the CYP11 family and six cancer types

Fan,Ziwei; Wang,Zhen; Chen,Weiran; Cao,Zhiwei; Li,Yixue

doi:10.3892/ol.2016.4567

Association between the CYP11 family and six cancer types

Authors:
- Ziwei Fan
- Zhen Wang
- Weiran Chen
- Zhiwei Cao
- Yixue Li
View Affiliations

Affiliations: School of Life Science and Technology, Tongji University, Shanghai 200092, P.R. China, Key Lab of Computational Biology, CAS‑MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, P.R. China
Published online on: May 13, 2016 https://doi.org/10.3892/ol.2016.4567
Pages: 35-40
Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cytochromes P450 (CYPs) are a major source of variability in pharmacokinetics and drug response. CYPs utilize a variety of small and large molecules as substrates in enzymatic reactions. The CYP genes may be divided into two groups: Endogenous CYPs (CYP family 7-51) and xenobiotic CYPs (CYP family 1-4). The aim of the present study was to investigate whether endogenous CYPs exhibit similar gene expression and mutations in various cancer types. The gene expression profiles and somatic mutations exhibited in colon adenocarcinoma, kidney renal clear cell carcinoma, liver hepatocellular carcinoma, lung squamous cell carcinoma, prostate adenocarcinoma and uterine corpus endometrial carcinoma were analyzed using data obtained from The Cancer Genome Atlas. The expression of CYP11A1 was significantly downregulated in all six cancer types. In addition, CYP11B1 and CYP11B2 exhibited the highest number of mutations among endogenous CYPs in all samples. As the CYP11 family is important for steroid biosynthesis, and previous studies have demonstrated that steroid hormones are associated with certain cancers, these results indicate a common role of the CYP11 family in various cancer types.

View Figures

View References

1	Berka K, Hendrychová T, Anzenbacher P and Otyepka M: Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site. J Phys Chem A. 115:11248–11255. 2011. View Article : Google Scholar : PubMed/NCBI
2	Thomas JH: Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet. 3:e672007. View Article : Google Scholar : PubMed/NCBI
3	Guengerich FP: Cytochrome p450 and chemical toxicology. Chem Res Toxicol. 21:70–83. 2008. View Article : Google Scholar : PubMed/NCBI
4	Cancer Genome Atlas Research Network. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al: Integrated genomic characterization of endometrial carcinoma. Nature. 497:67–73. 2013. View Article : Google Scholar : PubMed/NCBI
5	Adzhubei I, Jordan DM and Sunyaev SR: Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter. 7:Unit7.202013.
6	Kanehisa M, Golo S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M and Hirakawa M: From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res. 34:D354–D357. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hanukoglu I: Steroidogenic enzymes: Structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol. 43:779–804. 1992. View Article : Google Scholar : PubMed/NCBI
8	Payne AH and Hales DB: Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 25:947–970. 2004. View Article : Google Scholar : PubMed/NCBI
9	Moon JY, Moon MH, Kim KT, Jeong DH, Kim YN, Chung BC and Choi MH: Cytochrome P450-mediated metabolic alterations in preeclampsia evaluated by quantitative steroid signatures. J Steroid Biochem Mol Biol. 139:182–191. 2014. View Article : Google Scholar : PubMed/NCBI
10	Helmberg A: Twin genes and endocrine disease: CYP21 and CYP11B genes. Acta Endocrinol (Copenh). 129:97–108. 1993.PubMed/NCBI
11	Stowasser M, Gunasekera TG and Gordon RD: Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol. 28:1087–1090. 2001. View Article : Google Scholar : PubMed/NCBI
12	Alvarez-Madrazo S, Mackenzie SM, Davies E, et al: Common polymorphisms in the CYP11B1 and CYP11B2 genes: Evidence for a digenic influence on hypertension. Hypertension. 61:232–239. 2013. View Article : Google Scholar : PubMed/NCBI
13	Padmanabhan N, Padmanabhan S and Connell JM: Genetic basis of cardiovascular disease - the renin-angiotensin-aldosterone system as a paradigm. J Renin Angiotensin Aldosterone Syst. 1:316–324. 2000. View Article : Google Scholar : PubMed/NCBI
14	Davis RA, Miyake JH, Hui TY and Spann NJ: Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J Lipid Res. 43:533–543. 2002.PubMed/NCBI
15	Marx CE, Bradford DW, Hamer RM, Naylor JC, Allen TB, Lieberman JA, Strauss JL and Kilts JD: Pregnenolone as a novel therapeutic candidate in schizophrenia: Emerging preclinical and clinical evidence. Neuroscience. 191:78–90. 2011. View Article : Google Scholar : PubMed/NCBI
16	Hoehn K and Marieb EN: The endocrine system. Human Anatomy & Physiology (8th). Benjamin Cummings. (San Francisco, CA). 606–612. 2010.
17	Chyun YS, Kream BE and Raisz LG: Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology. 114:477–480. 1984. View Article : Google Scholar : PubMed/NCBI
18	Hu C, Rusin CG, Tan Z, Guagliardo NA and Barrett PQ: Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest. 122:2046–2053. 2012. View Article : Google Scholar : PubMed/NCBI
19	Claus EB, Risch N and Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 48:232–242. 1991.PubMed/NCBI
20	He Q, Liang CH and Lippard SJ: Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA. 97:5768–5772. 2000. View Article : Google Scholar : PubMed/NCBI
21	Colleoni M, Viale G, Zahrieh D, et al: Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: A study of preoperative treatment. Clin Cancer Res. 10:6622–6628. 2004. View Article : Google Scholar : PubMed/NCBI
22	Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M and Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 98:1406–1415. 2006. View Article : Google Scholar : PubMed/NCBI
23	Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC and Giovannucci E: Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev. 14:1262–1269. 2005. View Article : Google Scholar : PubMed/NCBI
24	Kaiser U, Hofmann J, Schilli M, Wegmann B, Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gazdar AF and Havemann K: Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer. 67:357–364. 1996. View Article : Google Scholar : PubMed/NCBI
25	Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, et al: Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst. 88:1127–1135. 1996. View Article : Google Scholar : PubMed/NCBI
26	Lointier P, Wildrick DM and Boman BM: The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res. 12:1327–1330. 1992.PubMed/NCBI
27	De Maria N, Manno M and Villa E: Sex hormones and liver cancer. Mol Cell Endocrinol. 193:59–63. 2002. View Article : Google Scholar : PubMed/NCBI
28	Gu S, Kounenidakis M, Schmidt EM, Deshpande D, Alkahtani S, Alarifi S, Föller M, Alevizopoulos K, Lang F and Stournaras C: Rapid activation of FAK/mTOR/p70S6K/PAK1-signaling controls the early testosterone-induced actin reorganization in colon cancer cells. Cell Signal. 25:66–73. 2013. View Article : Google Scholar : PubMed/NCBI
29	Koehler KF, Helguero LA, Haldosén LA, Warner M and Gustafsson JA: Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev. 26:465–478. 2005. View Article : Google Scholar : PubMed/NCBI
30	Patrone C, Cassel TN, Pettersson K, Piao YS, Cheng G, Ciana P, Maggi A, Warner M, Gustafsson JA and Nord M: Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol. 23:8542–8552. 2003. View Article : Google Scholar : PubMed/NCBI
31	Bardin A, Boulle N, Lazennec G, Vignon F and Pujol P: Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer. 11:537–551. 2004. View Article : Google Scholar : PubMed/NCBI
32	Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria JC, Vlastos G and Rapiti E: Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer. 117:1288–1295. 2011. View Article : Google Scholar : PubMed/NCBI
33	Kazmi N, Márquez-Garbán DC, Aivazyan L, Hamilton N, Garon EB, Goodglick L and Pietras RJ: The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manag. 1:259–272. 2012. View Article : Google Scholar : PubMed/NCBI
34	de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, et al: COU-AA-301 Investigators: Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 364:1995–2005. 2011. View Article : Google Scholar : PubMed/NCBI
35	Kim JJ, Kurita T and Bulun SE: Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 34:130–162. 2013. View Article : Google Scholar : PubMed/NCBI